These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


231 related items for PubMed ID: 11992742

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Selective cyclooxygenase-2 inhibitor].
    Hettich M, Thomae K.
    Internist (Berl); 1997 Oct; 38(10):1007. PubMed ID: 9432492
    [No Abstract] [Full Text] [Related]

  • 5. [Role of cyclooxygenase-2 (COG-2) in the etiology of pain].
    Nasonova VA.
    Ter Arkh; 2001 Oct; 73(5):56-7. PubMed ID: 11517752
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. COX-2 inhibitors: a review.
    Houston AM, Teach SJ.
    Pediatr Emerg Care; 2004 Jun; 20(6):396-9; quiz 400-2. PubMed ID: 15179150
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Controversies in COX-2 inhibitor therapy: closing remarks.
    Abramson SB, Furst DE, Hochberg MC, Patrono C.
    Clin Exp Rheumatol; 2001 Jun; 19(6 Suppl 25):S77-80. PubMed ID: 11695257
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Arthrosis drugs critically evaluated. Emphasis on cartilage protection].
    Wepner U.
    MMW Fortschr Med; 2002 Mar 28; 144(13):4-8. PubMed ID: 12001589
    [No Abstract] [Full Text] [Related]

  • 13. COX-1 and COX-2 inhibition: current status and future perspective.
    Greyn J, Lauwers MH, Vanlersberghe C, Camu F.
    Acta Anaesthesiol Belg; 1998 Mar 28; 49(3):175-83. PubMed ID: 9844704
    [No Abstract] [Full Text] [Related]

  • 14. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results].
    Oliw E, Wollheim FA.
    Lakartidningen; 2000 Jun 14; 97(24):2942-4. PubMed ID: 10900877
    [No Abstract] [Full Text] [Related]

  • 15. [A new class of nonsteroidal anti-inflammatory agents: COXIBs].
    Costantino S.
    Clin Ter; 2003 Jun 14; 154(1):5-6. PubMed ID: 12854276
    [No Abstract] [Full Text] [Related]

  • 16. An update on specific COX-2 inhibitors: the COXIBs.
    Gupta S, Crofford LJ.
    Bull Rheum Dis; 2001 Jun 14; 50(1):1-4. PubMed ID: 12092091
    [No Abstract] [Full Text] [Related]

  • 17. [Specific inhibitors of cyclooxygenase type 2] ].
    Tomasová-Studýnková J.
    Vnitr Lek; 2002 May 14; 48(5):403-8. PubMed ID: 12061207
    [Abstract] [Full Text] [Related]

  • 18. [Comparative safety of traditional non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors].
    Bannwarth B.
    Presse Med; 2002 Dec 07; 31(39 Pt 2):4S7-9. PubMed ID: 12518070
    [Abstract] [Full Text] [Related]

  • 19. Celecoxib: a COX-2 inhibitor.
    Andrews SA, Wallace CK, Davis RL.
    Am J Manag Care; 1999 Apr 07; 5(4):511-8; quiz 522-4. PubMed ID: 10387389
    [No Abstract] [Full Text] [Related]

  • 20. The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors.
    Szczeklik A, Sanak M.
    Clin Exp Allergy; 2002 Mar 07; 32(3):339-42. PubMed ID: 11940059
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.